Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:28 PM
Ignite Modification Date:
2025-12-24 @ 9:28 PM
NCT ID:
NCT00812032
Eligibility Criteria:
Inclusion Criteria:
* Type 2 DM with micro- or macroangiopathy.
* HbA1c 6-9 % (Mono-S method).
* Need for, or already on-going aspirin treatment.
* Age 50-75 years
* Antecubital forearm veins allowing technically good sampling for platelet studies
Exclusion Criteria:
* Diet controlled DM.
* Acute ischemic stroke, acute coronary syndrome, (myocardial infarction or unstable angina pectoris), or revascularization by PCI or by-pass surgery within the last 6 months.
* Acute or chronic kidney disease (P-cystatin C within the reference interval)
* Acute or chronic liver disease (ALAT ≤2 times the upper reference value).
* A history of gastric or duodenal ulcer disease.
* Need for treatment with anticoagulants, clopidogrel, NSAID's, or thiazolidinediones.
* Thrombocytopenia (platelet count \<150 x 109/L)
* Anticipated need for alteration of concomitant drug therapy during the course of the study.
* Enrollment in another clinical study.
* Contraindication(s) to aspirin treatment.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
50 Years
Maximum Age:
75 Years
Study:
NCT00812032
Study Brief:
Protocol Section:
NCT00812032